论文部分内容阅读
目的:观察金匮肾气丸治疗支气管哮喘--慢性阻塞性肺疾病重叠综合征(ACOS)患者的有效性。方法:将60例ACOS患者随机分成两组,两组患者给与相同的抗炎、平喘、扩张支气管治疗,治疗组另给金贵肾气丸每日2次,一次1丸,2周后观察两组患者临床疗效、外周血Th1、Th2细胞及白介素4、γ干扰素表达水平。结果:治疗组临床总有效率高于对照组,治疗组治疗后血清Th1升高,Th2降低,Th1/Th2升高,IL-4水平降低,IFN-γ水平升高,且与对照组相比,有显著差异(P<0.05)。结论:金匮肾气丸可安全有效地辅助治疗ACOS患者。
Objective: To observe the effectiveness of Jinguishenqi Pill in the treatment of patients with bronchial asthma - chronic obstructive pulmonary disease overlap syndrome (ACOS). Methods: Sixty patients with ACOS were randomly divided into two groups. The two groups were given the same anti-inflammatory, anti-asthmatic and bronchial expansion. The treatment group was given Jingui Shenqi Pills twice daily and once a pill for two weeks The clinical curative effect, Th1 and Th2 cells in peripheral blood and the expression of interleukin-4 and interferon-gamma in two groups were compared. Results: The total clinical effective rate in the treatment group was higher than that in the control group. The serum Th1, Th2, Th1 / Th2, IL-4 and IFN-γ in the treatment group were significantly higher than those in the control group , There was a significant difference (P <0.05). Conclusion: Jinkuishenqi pills can be safely and effectively adjuvant treatment of ACOS patients.